Peritoneal dialysis products contribute to Baxter's growth
This article was originally published in Clinica
Baxter's first-quarter net income rose by 10% to $164 million, on sales of $1.47 billion, a rise of 2% on the previous period. Excluding currency effects, sales increased 7%. The net income figure excludes $352 million relating to the acquisitions of Immuno International and Research Medical.